NCT06169280View on ClinicalTrials.gov

Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade Glioma

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2030

Conditions
Glioma, MalignantNew Diagnosis Tumor
Interventions
BIOLOGICAL

NSC-CRAd-S-pk7

NSC-CRAd-S-pk7 1·50 x 10⁸ NSCs loaded with1·875 x viral particles administered intra-tumorally on Day 0 and Day 15, then every 4 weeks for up to 6 total doses.

Trial Locations (1)

60611

RECRUITING

Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER